Cardiovascular Digital Health Journal (Feb 2022)

Risk factor management of atrial fibrillation using mHealth: The Atrial Fibrillation – Helping Address Care with Remote Technology (AF-HEART) Pilot Study

  • Lindsey R. Mitrani, MD,
  • Isaac Goldenthal, MS,
  • Jamie Leskowitz, RD,
  • Elaine Y. Wan, MD, FHRS,
  • Jose Dizon, MD,
  • Deepak Saluja, MD,
  • Ruth Masterson Creber, PhD,
  • Megan Reading Turchioe, PhD,
  • Robert R. Sciacca, EndScD,
  • Hasan Garan, MD,
  • Kathleen T. Hickey, EdD,
  • Judith Korner, MD, PhD,
  • Angelo B. Biviano, MD, FHRS

Journal volume & issue
Vol. 3, no. 1
pp. 14 – 20

Abstract

Read online

Background: Personalized treatment of atrial fibrillation (AF) risk factors using mHealth and telehealth may improve patient outcomes. Objective: The purpose of this study was to assess the feasibility of the Atrial Fibrillation Helping Address Care with Remote Technology (AF-HEART) intervention on the following patient outcomes: (1) heart rhythm tracking; (2) weight, alcohol, blood pressure (BP), and sleep apnea reduction; (3) AF symptom reduction; and (4) quality-of-life (QOL) improvement. Methods: A total of 20 patients with AF undergoing antiarrhythmic therapy, cardioversion, and/or catheter ablation were enrolled and followed for 6 months. The AF-HEART intervention included remote heart rhythm, weight, and BP tracking; televisits with a dietician focusing on AF risk factors; and referrals for sleep apnea and hypertension treatment. Results: Patients transmitted a median of 181 rhythm recordings during the 6-month follow-up period. Patients lost an average of 3.5 kilograms at 6 months (P = .005). Patients had improved SF-12 scores (P = .01), AFSS score (P = .01), EQ-5D score (P = .006), and AFEQT Global Score (P = .03). There was significant correlation between weight loss and decrease in symptom severity (r = -0.45, P = .05), and between % weight loss and decrease in symptom severity (r = -0.49, P = .03). Conclusion: This study described the feasibility of the AF-HEART intervention for (1) consistent remote tracking of heart rhythm, weight, and BP; (2) achievement of weight loss; (3) reduction of symptoms; and (4) improvement in QOL. Expansion to a larger randomized study is planned.

Keywords